TY - JOUR
T1 - Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium
AU - Gaudet, Mia M.
AU - Olshan, Andrew F.
AU - Chuang, Shu Chun
AU - Berthiller, Julien
AU - Zhang, Zuo Feng
AU - Lissowska, Jolanta
AU - Zaridze, David
AU - Winn, Deborah M.
AU - Wei, Qingyi
AU - Talamini, Renato
AU - Szeszenia-Dabrowska, Neolilia
AU - Sturgis, Erich M.
AU - Schwartz, Stephen M.
AU - Rudnai, Peter
AU - Eluf-Neto, Jose
AU - Muscat, Joshua
AU - Morgenstern, Hal
AU - Menezes, Ana
AU - Matos, Elena
AU - Bucur, Alexandru
AU - Levi, Fabio
AU - Lazarus, Philip
AU - La Vecchia, Carlo
AU - Koifman, Sergio
AU - Kelsey, Karl
AU - Herrero, Rolando
AU - Hayes, Richard B.
AU - Franceschi, Silva
AU - Wunsch-Filho, Victor
AU - Fernandez, Leticia
AU - Fabianova, Eleonora
AU - Daudt, Alexander W.
AU - Dal Maso, Luigino
AU - Curado, Maria Paula
AU - Chen, Chu
AU - Castellsague, Xavier
AU - Benhamou, Simone
AU - Boffetta, Paolo
AU - Brennan, Paul
AU - Hashibe, Mia
N1 - Funding Information:
Grant from the US National Institutes of Health (NIH), National Cancer Institute (NCI) [R03CA113157]. The individual studies were funded by the following grants: Milan study: Italian Association for Research on Cancer (AIRC); Aviano and Italy multicentre studies: Italian Association for Research on Cancer (AIRC), Italian League Against Cancer and Italian Ministry of Research; France study: Swiss League against Cancer [KFS1069-09-2000], Fribourg League against Cancer [FOR381.88], Swiss Cancer Research [AKT 617] and Gustave-Roussy Institute [88D28]; Swiss study: Swiss League against Cancer and the Swiss Research against Cancer/Oncosuisse [KFS-700, OCS-1633]; Central Europe study: World Cancer Research Fund and the European Commission’s INCO-COPERNICUS Programme [Contract No. IC15-CT98-0332]; New York study: National Institutes of Health (NIH) US [P01CA068384 K07CA104231]; Seattle study: National Institutes of Health (NIH) US [R01CA048896, R01DE012609]; Boston study: National Institutes of Health (NIH) US [R01CA078609, R01CA100679]; Iowa study: National Institutes of Health (NIH) US [NIDCR R01DE11979, NIDCR R01DE13110, NIH FIRCA TW01500] and Veterans Affairs Merit Review Funds; North Carolina study: National Institutes of Health (NIH) US [R01CA61188], and in part by a grant from the National Institute of Environmental Health Sciences [P30ES010126]; Tampa study: National Institutes of Health (NIH) US [P01CA068384, K07CA104231, R01DE13158]; Los Angeles study: National Institute of Health (NIH) US [P50CA90388, R01DA11386, R03CA77954, T32CA09142, U01CA96134, R21ES011667] and the Alper Research Programme for Environmental Genomics of the UCLA Jonsson Comprehensive Cancer Centre; Houston study: National Institutes of Health (NIH) US [R01ES11740, R01CA100264]; Puerto Rico study: jointly funded by National Institutes of Health (NCI) US and NIDCR intramural programmes; Latin America study: Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) Argentina, IMIM (Barcelona), Funda¸cão de Amparo à Pesquisa no Estado de São Paulo (FAPESP) [No 01/01768-2], and European Commission [IC18-CT97-0222]; IARC Multicentre study: Fondo de Investigaciones Sanitarias (FIS) of the Spanish Government [FIS 97/0024, FIS 97/0662, BAE 01/5013], International Union Against Cancer (UICC), and Yamagiwa-Yoshida Memorial International Cancer Study Grant.
PY - 2010/2/1
Y1 - 2010/2/1
N2 - Background: Head and neck cancer (HNC) risk is elevated among lean people and reduced among overweight or obese people in some studies; however, it is unknown whether these associations differ for certain subgroups or are influenced by residual confounding from the effects of alcohol and tobacco use or by other sources of biases. Methods: We pooled data from 17 case-control studies including 12 716 cases and the 17 438 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for associations between body mass index (BMI) at different ages and HNC risk, adjusted for age, sex, centre, race, education, tobacco smoking and alcohol consumption. Results: Adjusted ORs (95% CIs) were elevated for people with BMI at reference (date of diagnosis for cases and date of selection for controls) ≤18.5 kg/m2 (2.13, 1.75-2.58) and reduced for BMI >25.0-30.0 kg/m2 (0.52, 0.44-0.60) and BMI ≥30 kg/m2 (0.43, 0.33-0.57), compared with BMI >18.5-25.0 kg/m2. These associations did not differ by age, sex, tumour site or control source. Although the increased risk among people with BMI ≤18.5 kg/m2 was not modified by tobacco smoking or alcohol drinking, the inverse association for people with BMI > 25 kg/m2 was present only in smokers and drinkers. Conclusions: In our large pooled analysis, leanness was associated with increased HNC risk regardless of smoking and drinking status, although reverse causality cannot be excluded. The reduced risk among overweight or obese people may indicate body size is a modifier of the risk associated with smoking and drinking. Further clarification may be provided by analyses of prospective cohort and mechanistic studies.
AB - Background: Head and neck cancer (HNC) risk is elevated among lean people and reduced among overweight or obese people in some studies; however, it is unknown whether these associations differ for certain subgroups or are influenced by residual confounding from the effects of alcohol and tobacco use or by other sources of biases. Methods: We pooled data from 17 case-control studies including 12 716 cases and the 17 438 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for associations between body mass index (BMI) at different ages and HNC risk, adjusted for age, sex, centre, race, education, tobacco smoking and alcohol consumption. Results: Adjusted ORs (95% CIs) were elevated for people with BMI at reference (date of diagnosis for cases and date of selection for controls) ≤18.5 kg/m2 (2.13, 1.75-2.58) and reduced for BMI >25.0-30.0 kg/m2 (0.52, 0.44-0.60) and BMI ≥30 kg/m2 (0.43, 0.33-0.57), compared with BMI >18.5-25.0 kg/m2. These associations did not differ by age, sex, tumour site or control source. Although the increased risk among people with BMI ≤18.5 kg/m2 was not modified by tobacco smoking or alcohol drinking, the inverse association for people with BMI > 25 kg/m2 was present only in smokers and drinkers. Conclusions: In our large pooled analysis, leanness was associated with increased HNC risk regardless of smoking and drinking status, although reverse causality cannot be excluded. The reduced risk among overweight or obese people may indicate body size is a modifier of the risk associated with smoking and drinking. Further clarification may be provided by analyses of prospective cohort and mechanistic studies.
UR - http://www.scopus.com/inward/record.url?scp=77956269633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956269633&partnerID=8YFLogxK
U2 - 10.1093/ije/dyp380
DO - 10.1093/ije/dyp380
M3 - Article
C2 - 20123951
AN - SCOPUS:77956269633
SN - 0300-5771
VL - 39
SP - 1091
EP - 1102
JO - International journal of epidemiology
JF - International journal of epidemiology
IS - 4
M1 - dyp380
ER -